Posts Tagged ‘Among’

Genedata Screener Now Supports Streamlined Collaboration among Pharmas and CROs














Basel, Switzerland (PRWEB) May 12, 2015

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that the Genedata Screener® platform supports data- and result-sharing with Contract Research Organizations (CROs). Genedata Screener provides a framework for systematic import, processing, and end-result propagation for all types of screening experiments, making it ideal for different collaboration models and partner ecosystems among pharmaceutical companies and CROs. As used by Roche, Genedata Screener is a comprehensive software solution supporting global operations, leveraged as a collaboration platform to help expedite drug discovery, reduce data analysis costs, and lower overhead for pharmaceutical R&D.

Web-based and cloud-compatible, Genedata Screener can be used as a data analysis and exchange platform. Installed at a CRO site, on-site or in the cloud, it enables a pharma’s CRO partner to easily exchange data with the pharma’s Screener instance. The system’s inherent business logic allows pharmas to maintain consistent workflows with their company-specific business rules for results regardless of the CRO doing the analysis.

Secure and Consistent Platform for Collaborative Research Lowers Total Cost of Ownership

Pharmaceutical companies – both large and small – are using collaborative research to help replenish therapeutic pipelines and advance innovation. Such collaborative research models provide access to specific technologies, streamline operations, lower costs, and accelerate drug discovery. Outsourcing screening and the corresponding data analysis to CROs is a valuable research model and business strategy for many leading pharmaceutical companies. This model increases flexibility for drug discovery and draws from a broader expertise for improved results.

Successful collaborative research with external partners requires all parties to have complete insight into the data produced by an experiment, the data analysis methods applied, and the rationale for decision making (e.g. specific artifact corrections or decisions on hit calling and compound progression). Having both in-house and external researchers using the same consistent methodology and standardized processing of results is critical for maintaining research integrity. Genedata Screener creates a framework for a successful collaboration paradigm as it provides a platform for sharing business rules and analysis methodologies as well as strict control of access, (re-)analysis, and modification permissions. Furthermore, all steps and modifications are tracked along the process, yielding a full audit trail across different functions and organizations.

Enabling CROs to collaborate with in-house scientists, Genedata Screener not only extends the lab bench, it also supports a variety of collaboration models (i.e. multi-sided and peer-to-peer). It helps pharmaceutical companies go beyond commodity screening with end-to-end data sharing and analysis, which can transfer raw data and results between two instances of Screener. Additional platform features include:


Automated Data Exchange for long-term collaboration spanning several projects. Results are synchronized through different Genedata Screener instances to easily collect and centralize project data and compound results.
IP Protection as the collaboration server is a Genedata Screener instance that requires precise definition of project access and information content per project.
Large Dataset Analysis – even in the cloud – to enable cost-effective and streamlined management and delivery of data analysis.

“Genedata Screener, used as a modern collaboration platform, continues to support evolving R&D needs without organizations making additional technology investments,” noted Dr. Othmar Pfannes, CEO of Genedata. “And, the beauty of this industry-leading low TCO is that it also accelerates the pace of novel drug discovery.”

About Genedata

Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com. Follow Us on LinkedIn.























Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.









Related Small Business Press Releases

College of Staten Island, CUNY, Professor Included Among ‘100 Leading Global Thinkers’











Michael Mandiberg celebrates with fellow honorees during Foreign Policy’s 100 Leading Global Thinkers of 2014 reception. (DAKOTA FINE/photo)

STATEN ISLAND, N.Y. (PRWEB) November 25, 2014

An educator at the College of Staten Island (CSI), CUNY, was recognized during a recent Washington, D.C. gala as one of the “100 Leading Global Thinkers of 2014.”

Michael Mandiberg, an associate professor in CSI’s Department of Media Culture in the Division of Humanities and Social Sciences, was selected for the distinction by Foreign Policy (FP) magazine for his work on Art+Feminism, an initiative focused on bolstering a more balanced presentation of art, feminism, gender studies and LGBTQ issues on Wikipedia.

Prior to the Nov. 17 dinner celebration in the Four Seasons Hotel, Mandiberg and co-honorees from across the globe gathered with U.S. Secretary of State John Kerry for “Transformational Trends: A Year of Disruptive Thinking,” a policy conference, now in its third year, where Kerry gave the keynote address.

The event was jointly sponsored by FP and the State Department’s Policy Planning Staff. Others honorees included such people as artist Kara Walker; cryptographer Phil Zimmerman; Hong Kong student activist Joshua Wong, and Drs. Kevin Whaley and Larry Zeitlin, creators of the Ebola drug Zmapp.

Mandiberg and his collaborators – Siân Evans, Dorothy Howard, Richard Knipel, Jacqueline Mabey and Laurel Ptak – were recognized for organizing the Art+Feminism Wikipedia Edit-a-thon. On Feb. 1, 150 people gathered at Eyebeam, a center for art and technology in New York City, to edit Wikipedia entries on women, art, feminism, and related subjects. They were joined by approximately 500 others in 30 satellite events across three continents.

“We do this work because it is the right thing to do, without thinking of a prize or reward,” Mandiberg said. “My collaborators and I are deeply honored to be included among a group of such amazing honorees.”

Wikipedia is the sixth most visited website, according to Internet data provider Alexa, but only 13 percent of Wikipedia’s contributors are female.

“Professor Mandiberg’s innovative work blends technology, art, and explorations of systems of exchange,” said Nan M. Sussman, dean of Humanities and Social Sciences at CSI. “The 2014 Art+Feminism Wikipedia project was an international collaborative initiative that resulted in more than 101 new articles created and 90 articles revised in an attempt to address the gender imbalance in Wikipedia. He brings this same interdisciplinary curiosity and social critique to his classroom.”

“Our department,” added Professor Ying Zhu, PhD., chair of CSI’s Department of Media Culture, “is very proud of Michael’s socially and politically engaging work.”

Many more editing meet-ups have followed since the Art+Feminism inaugural gathering. In October, the program coordinated the first in a series of workshops, called “Train the Trainers,” to prepare aspiring activist editors for future projects.

The next international Art+Feminism Wikipedia Edit-a-thon will take place March 7 and 8, 2015, the weekend of International Women’s Day. The Museum of Modern Art (MoMA) will host the anchor New York City event.

In addition to his position as an associate professor at CSI, Mandiberg is a member of the doctoral faculty at the CUNY Graduate Center. An interdisciplinary artist and scholar, he directs the New York Arts Practicum, a summer arts institute where participants experientially learn to bridge their lives as art students into lives as artists.

Media Contact: Barton Horowitz

Relevant Public Relations, LLC

Headquarters: 718 682 1509

Mobile: 917 715 8761

Email: Bhorowitz(at)RelevantPR(dot)com























Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.









More Foreign Exchange Press Releases

Statera, a Leading Provider of Technology Services that Drive Business Transformation, Named Among Top Network integrators by Phoenix Business Journal












Englewood, CO (PRWEB) May 17, 2013

Statêra, “We Make Cloud and IT Services Easy™,” is pleased to announce that the Phoenix Business Journal’s THE BIZ LIST Published May 10th, 2013 of Phoenix’s Top Network Integrators named Statêra sixth on the list. The Phoenix Business Journal ranks network integration companies by the number of valley integration employees. For over a decade, Statêra has provided expert IT services, staffing, strategy and consulting, and IT project management, and more recently added outsourcing and cloud services brokerage.

“It’s great to be recognized as one of the top Network Integrators in Arizona when measured by employee count, but we are also excited by our incredible customer satisfaction, and our deep list of brand recognized clients as a true measurement of success. With a new and improved value proposition, and a singular focus on our customers use of technology, look for Statêra to move up this list in the future,” said Tim Bauer, Managing Partner, Statêra.

“We aim to continue to be recognized as a top network integrator and software developer in all the markets we serve, in addition to expanding our cloud services brokerage and other service offerings,” added Carl Fitch, CEO, Statêra.

About Statêra

Statêra is a leading IT services provider that helps companies to optimize performance by mapping strategic goals and objectives to IT initiatives. With over a decade of experience, Statêra leverages best practices and uses today’s top technology solutions to provide powerful insight into your enterprise, solve your mission-critical problems, drive return on investment and transform your business. We are experts in moving our clients to the Cloud, CRM, web and mobile platforms, and collaboration software, as well as custom software applications development. Our IT services, IT project management, strategy consulting and managed cloud services brokerage balance people, processes and technology to get your technology needs met on time and on budget. Headquartered outside of Denver, Colorado, Statêra has local offices in Dallas, Texas; Phoenix, Arizona; Salt Lake City, Utah; and Seattle, Washington, and clients worldwide. Call us at 1.866.697.0266 or visit http://www.Statera.com.











Attachments






















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.









Related Outsourcing Press Releases